Ingredion announced an all-cash acquisition of Tate & Lyle for about $5 billion, offering Tate & Lyle shareholders a 59% premium per share. The deal broadens Ingredion's product range in texturants, sugar reduction, and recipe development, and is expected to generate $130 million in annual cost synergies by 2030. The acquisition, backed by both companies' boards, is set to close in the second half of 2027 pending approvals. Ingredion plans to finance the deal through cash, new debt, and bridge financing, aiming to reduce leverage within 18 months after closing.
Cyabra, an AI-driven disinformation intelligence company, has secured a contract worth over $500,000 to provide its technology to a leading international research institute focused on tracking global hate speech. The platform will help identify coord...
Ormat Technologies introduced the Ormega100, the industry's largest binary power generation unit delivering 100 MW output, designed to accelerate commercialization and scaling of Enhanced Geothermal Systems (EGS). With 60 years of expertise and exten...
Novo Nordisk announced positive Phase 3 trial results for CagriSema, a once-weekly therapy combining an amylin analog with a GLP-1 receptor agonist, which significantly reduced HbA1c and body weight in adults with Type 2 diabetes. The company also sh...
Hyperscale Data's stock surged 23.18% in premarket trading driven by a broader market rally and increased risk appetite among investors. The company reported holding 704.34 Bitcoin, valued at about $51.8 million as of May 31, 2026, reinforcing its di...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Graphic Packaging Holding Company, Immutep Limited, and Phreesia, Inc. These lawsuits allege misleading statements or no...
